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SUMMAry
AiM: The aim of this double-blind, randomized, placebo-controlled clinical study was to evaluate the anal-
gesic effects of preoperative/postoperative ibuprofen and acetaminophen use after bonding and to find a 
relation between the pain level and the amount of prostaglandin released.
MATEriAlS AND METhODS: Forty-eight patients were included and randomly divided to three equal groups 
that received either ibuprofen, acetaminophen or placebo for pain relief. The pain levels were measured 
before bonding, after bonding, at first, second, third, and seventh days on a 100 mm visual analogue 
scale (VAS) and gingival crevicular fluid (GCF) samples were collected at the same time intervals to meas-
ure the amount of prostaglandin E2 (PGE2) released. PGE2 levels were determined with EliSA test. The 
results were evaluated with Wilcoxon and Kruskal–Wallis tests with Bonferroni correction.
rESUlTS: Acetaminophen and placebo groups showed similar pain levels during the first 2 days, whereas 
ibuprofen group showed lower pain levels during the first day after bonding. PGE2 levels did not show 
statistically significant difference in time within the analgesic groups. No significant relation between the 
pain perceived and PGE2 released was found.
liMiTATiONS: The biggest limitation of this study is the subjective nature of pain and its method of evaluation.
CONClUSiONS: The perception of pain by patients taking ibuprofen and acetaminophen at pre/post appli-
ance placement was not different from patients taking placebo. No time-related differences in PGE2 level 
were found between the groups and no significant correlation was found between the perception of pain 
and PGE2 levels.
Introduction
Orthodontic treatment is not painless, especially in the first 
weeks of appliance placement. Orthodontic literature is full 
of reports that mention about the negative effects of pain 
on the patients’ daily activities after the placement of fixed 
appliances (Brown and Moerenhout, 1991; Sergl et  al., 
1998). Therefore, pain caused by the orthodontic appliances 
remain to be an issue that need not be underestimated by 
the clinician.
Orthodontic pain is caused by the release of algogenic 
materials like prostaglandins (PG), histamin, bradykinin, 
and  leukotrienes. Several pain control methods (Roth and 
Thrash, 1986; Fujiyama et al., 2008; Hwang et al., 1994) 
have been introduced and the most commonly used method 
still remains to be the pharmacological administration of 
analgesics. Non-steroidal anti-inflammatory drugs (NSAID) 
that block prostaglandin production are commonly given to 
patients for pain relief. The analgesic efficacy of different 
analgesics like aspirin, ibuprofen, flurbiprofen, naproxen 
sodium and acetaminophen have been tested for the con-
trol of orthodontic pain (Bernhardt et al., 2001; Polat and 
Karaman, 2005; Bird et  al., 2007; Bradley et  al., 2007; 
Krishnan, 2007; Xiaoting et  al., 2010). However, these 
chemicals are also responsible for the initiation of the oste-
oclastic activity and therefore a delay in orthodontic tooth 
movement can be expected. Orthodontic literature is lack-
ing information about the efficacy of different type of anal-
gesics and their relevance to the release of prostaglandins. 
The purpose of this study is to find a relation between the 
analgesic efficacy of two types of analgesics, ibuprofen and 
acetaminophen, given both pre- and post-treatment and the 
level of prostaglandin E
2
 (PGE2) released after initial arch-
wire placement.
Materials and methods
This prospective, randomized, double-blind, placebo-
controlled study was approved by the Baskent University 
Institutional Review Board and Ethics Committee. Sixty 
orthodontic patients who were scheduled to receive fixed 
orthodontic treatment agreed to participate in this study. 
A  detailed medical history was taken for each patient. 
Both the parents and the patients were informed about the 
procedure, and an informed consent was obtained.
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The following selection criteria were required for partici-
pation: 1. no prophylactic antibiotic coverage required, 2. no 
history of systemic diseases or allergies, 3. no current use of 
antibiotics or analgesics, 4. no contraindication to the use of 
NSAID, 5. no teeth extraction at least 4 weeks before bond-
ing, 6. no history of orthodontic treatment, 7. not being in the 
menstrual period for female patients and 8. minimal crowding 
of maximum 7 mm that can be treated without extractions.
Proposed treatments were nonextraction but patients 
with open bites were excluded from the study. All of the 
patients received an education for maintaining the optimum 
oral hygiene and the patients with gingival problems were 
included to the study after periodontal therapy.
Randomization
The flow chart of the study is given in Figure 1. Forty-six 
patients were randomly allocated to one of three study 
groups in order. The groups were named as A, B, and C and 
both the patient and the investigator (ZT), who was respon-
sible from the clinical part of the study, did not have any 
knowledge about the type of analgesic that were given to 
each group. The tablets were identical in shape and colour 
and did not have any markings or labels that represented 
brand name. The tablets were put in small pill boxes with a 
sticker containing the name of the group. The pills were put 
in the boxes by the second investigator, and the first investi-
gator who coordinated the clinical part of the study did not 
have any knowledge about the grouping.
Study groups
Three experimental groups were predetermined: group A, 
400 mg ibuprofen; group B, 500 mg acetaminophen; group 
C, lactose placebo capsule. In all groups, the patients took 
two tablets, one tablet an hour before the appointment and 
the other six hours after bonding. Patients were instructed 
not to take any additional analgesics.
In order to stimulate a routine clinical set-up, brackets 
were only placed to upper 10 teeth including the second 
promolars and first molars were banded. After the place-
ment of upper appliances, 0.014 inch archwire was placed 
for levelling.
Pain assessment
Subjects were given routine post-treatment instructions and 
asked to complete a questionnaire at appropriate intervals 
during the week after the bonding appointment. The 
questionnaire was in the format of a six-page booklet that 
contained 100 mm horizontal visual analogue scales (VAS) 
on which the patient marked the degree of discomfort at the 
indicated time periods. The patients were instructed to make 
a check on the scale at each time interval to represent the 
perceived severity of pain during each of the three activities: 
chewing, fitting the front teeth, and fitting the back teeth. 
Incidence and severity of pain were recorded by the patient 
prior to bonding, right after the bonding, and on the first, 
second, third and seventh day after bonding. Patients were 
asked to return the questionnaire on the seventh day.
48 subjects were 
randomized
16 subjects 
Enrolled to 
group C 
(Placebo)
15 subjects 
Enrolled to 
group B 
(Acetaminophen
17 subjects
Enrolled to 
group A
(Ibuprofen)
Additional 
dose 
consumption
(n=2) 
No loss during 
follow-up.
Lost during 
follow-up
(n=1)
Analysed
(n=15)
Not analysed
(n=2)
(Additional 
dose 
consumption) 
Analysed
(n=15)
Not analysed
(n=0)
Analysed
(n=15)
Not analysed
(n=1)
(Lost contact 
during follow 
up) 
Figure 1 The flow chart of the study.
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Gingival crevicular fluid collection
Gingival crevicular fluid (GCF) was collected by means of 
Periopaper (Oraflow, New York, USA) from the mesial and 
distobuccal sites of the two canines using a standardized 
method at each time interval. Briefly, each tooth included in 
the study was isolated with cotton rolls, and the tooth surface 
was dried gently with air. The strip was then inserted 1 mm 
into the sulcus and left in situ for 30 seconds. The amount 
of GCF was measured with Periotron 8000 (Oraflow, New 
York, USA). After collection, it was placed in Eppendorf 
tubes and immediately stored at −80 degree Celsius until 
the day for the ELISA test.
Determination of prostaglandin E2 levels
Prostaglandin E
2
 EIA Kit–Monoclonal (Cayman Chemical 
Company, Ann Arbor, Michigan, USA) was used to evalu-
ate the concentration of PGE2 in the collected GCF sam-
ples. This kit is based on the competition of PGE2 and 
PGE2–acetylcholinesterase complex (PGE2 tracer) for a 
certain amount of PGE2 monoclonal antibody. All tests 
for the determination of PGE2 levels were performed at 
Baskent University, Faculty of Medicine, Department of 
Microbiology.
The samples, which were stored in Eppendorf tubes prior 
to the analysis, were diluted with 75 μl/strip buffer solution, 
according to the manufacturer instructions. The samples 
were shaken at least 15 seconds in Vortex machine. After 
the placement of the samples into the wells (50 μl per well), 
PGE2 tracer and PGE2 monoclonal antibody were added in 
an amount of 50 μl into the wells. The test plate cover was 
closed and incubated at 4 degree Celsius for 18 hours. After 
incubation the plate was washed with the wash buffer for five 
times and Ellman’s reagent was added in the wells. Then the 
plate was covered with a plastic membrane and incubated 
in an orbital shaker in the dark for 80 minutes. The colour 
density seen on the plate was read with ELx800 Universal 
Microplate Reader (BioTek Instruments, Vermont, USA). 
The density of the colour and the concentration of PGE2 
were seemed to be inversely correlated. Standard curves 
were created for each kit and the concentration of PGE2 
in the GCF was calculated with the implication of density 
values on these standard curves. PGE2 concentrations were 
found as pg/μl.
Statistical analysis
The statistical evaluation of the data was made by a profes-
sional statistical expert using SPSS for Windows 11.5 soft-
ware (SPSS Inc., Chicago, Illinois, USA). The distribution 
of the VAS levels and PGE2 concentrations was checked 
using the Shapiro–Wilk Test. Descriptive statistics were 
shown with median (minimum–maximum) values. Age dif-
ferences were evaluated using one way analysis of variance. 
All of the analyses were repeated for chewing, fitting back 
teeth, and fitting anterior teeth.
The differences in each drug group over time by means of 
pain and PGE2 values were evaluated using Wilcoxon test 
with Bonferroni correction. Since 45 multiple comparisons 
were made, a significance value of P < 0.0011 was consid-
ered significant.
The differences between the groups over time by means 
of pain and PGE2 values were evaluated using Kruskal–
Wallis test with Bonferroni correction. Eighteen multiple 
comparisons were made and a significance value of P < 
0.003 was considered significant.
Any possible relation between pain levels and PGE2 
released at each time interval was checked using Spearman 
correlation analysis with Bonferroni Correction. A signifi-
cance level of P < 0.0011 was preset.
Results
All of the 48 patients returned their forms back; however, 
two patients were excluded from the study for taking rescue 
medication and one patient for missing one of the GCF col-
lection appointments. The average age at enrollment for the 
three groups was not significantly different from each other 
as shown in Table 1. Gender differences are not taken into 
consideration.
The pain levels of the groups after initial archwire 
placement
In all of the groups, the pain level peaked within 1  day 
after archwire placement. The average pain levels at Day 1 
were similar for acetaminophen and placebo groups during 
chewing and fitting front teeth. The average pain reduction 
for the ibuprofen group was superior to both placebo and 
acetaminophen during chewing and fitting front teeth and 
Table 1 Distribution of the study groups.
Group Analgesic Mean age Minimum age Maximum age F P Girl Boy
A Ibuprofen 14.66 ± 2.06 11.9 20.5 8 7
B Acetaminophen 14.34 ± 1.91 10.8 16.3 0.91 0.913 11 4
C Placebo 14.50 ± 2.16 11.5 19.7 12 3
Total 14.50 ± 2.00 10.8 20.5 31 14
All the data are presented as mean (95% confidence interval).
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the differences were statistically significant. (P  <  0.0011; 
Table 2).
At Day 2, significant pain levels were measured for both 
acetaminophen and placebo groups during chewing. The 
pattern of pain was similar between the ibuprofen and the 
acetaminofen groups during fitting front teeth and fitting 
back teeth and only the placebo group reported significant 
pain during this functional activity at Day 2. (P < 0.0011; 
Table 2).
At Day 3, none of the analgesic groups reported signifi-
cant pain levels but the placebo group still experienced sig-
nificant amount of pain. (P < 0.0011) (Table 2).
Evaluation of PGE2 levels
In the placebo group the PGE2 levels were found as 
22.33±17.21 pg/μl, 16.81 ± 11.69 pg/μl, 17.33 ± 13.53 pg/μl, 
21.37 ± 24.33 pg/μl, 17.66 ± 14.90 pg/μl, 16.18 ± 10.08 pg/μl 
at the predetermined time intervals, respectively. The differ-
ence was not significant in all time intervals. (P < 0.0011).
In the ibuprofen group, the mean PGE2 levels were meas-
ured as 14.53 ± 13.27 pg/μl, 9.27 ± 4.81 pg/μl, 19.30 ± 17.25 
pg/μl, 14.52 ± 13.78 pg/μl, 9.96 ± 7.16 pg/μl, 11.59 ± 11.84 
pg/μl and the mean PGE2 levels for the acetaminophen 
group were 16.14 ± 12.59 pg/μl, 10.89 ± 10.53 pg/μl, 
16.66 ± 14.39 pg/μl, 21.78 ± 40.11 pg/μl, 14.63 ± 11.35 
pg/μl, 15.91 ± 13.705 pg/μl, respectively. For these two 
analgesic groups, the mean PGE2 levels in time were also 
insignificant (P < 0.0011) (Table 3).
The mean PGE2 levels of the analgesic groups were lower 
than placebo in some time intervals but the differences were 
not statistically significant. (P > 0.003).
Correlation between pain and PGE2 levels
No associations were found between the PGE2 levels and 
the intensity of pain at any time interval. However, since the 
correlation analyses are mostly dependent on the number 
of subjects, the ibuprofen and acetaminophen groups were 
merged and re-evaluated to increase the strength of the 
analysis. Nevertheless no significant difference was found 
between the intensity of pain and PGE2 levels (P > 0.05; 
Table 4)
Discussion
Pain and discomfort are one of the most common com-
plaints of orthodontic patients, especially on the first week 
Table 2 The pain levels of the three groups at measured function and time intervals.
Ibuprofen Acetaminophen Placebo P
Chewing
Before 
bonding
0.00 (0–0) 0.00 (0–0)*,** 0.00 (0–0)*,**,*******
After bonding 0.00 (0–6,7) 0,00 (0–4.3)***,**** 0.34 (0–5.6)****,******** 0.769
Day 1 4.67 (0–10) 6.36 (1.5–1.0)*,***,***** 7.40 (0–9.3)*,***** 0.146
Day 2 5.40 (0–10) 5.30 (0–10)**,****,****** 7.16 (2.8–9.7)**,****,****** 0.030
Day 3 2.90 (0–8.5) 2.81 (0–9.7) 6.25 
(1.5–10.0)*******,********,*********
0.027
Day 7 0.74 (0–7.0) 0.45 (0–2.5)*****,****** 0.00 (0–6.0)*****,******,********* 0.831
Fitting front teeth
Before 
bonding
0.00 (0–0.9) 0.00 (0–1)* 0.00 (0–0)*,***,****
After bonding 0.00 (0–4.1) 0.00 (0–4.3)** 0.0 (0–5.3)**,*****,****** 0.564
Day 1 2.69 (0–10.0) 6.34 (0–10)*,** 6.05 (2.8–9.4)*,** 0.524
Day 2 5.00 (0–10) 4.79 (0–10) 6.58 (2.6–10.0)***,*****,******* 0.157
Day 3 2.85 (0–9.4) 2.43 (0–9.4) 5.18 (1.0–10.0)****,******,******** 0.203
Day 7 0.85 (0–7.8) 0.50 (0–8.4) 0.64 (0–6.2)*******,******** 0.603
Fitting back teeth
Before 
Bonding
0.00 (0–3.5) 0.00 (0–0) 0.00 (0–0)*,**
After bonding 0.80 (0–6.6) 0.00 (0–6.5) 0.47 (0–6.4)*** 0.712
Day 1 5.30 (0–10) 5.13 (0–9.1) 7.11 (0–10) 0.235
Day 2 5.28 (0–10) 4.04 (0–9.2) 6.68 (3.8–9.7)*,***,**** 0.030
Day 3 2.23 (0–8.5) 2.82 (0–8.7) 6.17 (1.9–10.0)**,***** 0.015
Day 7 0.90 (0–6.6) 0.00 (0–2.4) 0.00 (0–4.8)****,***** 0.652
*Significant differences were detected between before bonding and Day 1 (P < 0.0011); **Significant differences were detected between after bonding 
and Day 1 (P < 0.0011); ***Significant differences were detected between before bonding and Day 2 (P < 0.0011); ****Significant differences were 
detected between before bonding and Day 3 (P < 0.0011); *****Significant differences were detected between after bonding and Day 2 (P < 0.0011); 
******Significant differences were detected between after bonding and Day 3 (P < 0.0011); *******Significant differences were detected between Day 2 
and Day 7(P < 0.0011); ********Significant differences were detected between Day 3 and Day 7 (P < 0.0011).
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of fixed appliance placement. The severity of pain derived 
from orthodontic appliances vary greatly by age, type of 
force, and personality type (Salmassian et  al., 2009) and 
even the appliance acceptance of patients after 6  months 
could be predicted from their attitude toward treatment and 
the amount of discomfort experienced (Doll et al., 2000). 
With such an importance on patient compliance and com-
fort, pain control and management should be a priority for 
the clinician.
Tooth movement is a complex phenomenon. According 
to the pressure-tension theory, tooth movement occurs in 
three stages: obstruction in blood flow after the applica-
tion of pressure to the periodontal ligament (PDL), release 
of chemical messengers, and activation of bone resorp-
tion (Sandy and Harris, 1984; Reitan and Rygh, 2007). 
Prostaglandin E2 and interleukin-1 β, which are important 
for the cellular response in the initiation of bone resorption, 
are released in the PDL and the GCF within a short time 
after the application of pressure and mediators such as pros-
taglandin E2 and interleukin-1β are involved in the media-
tion of orthodontic pain (Celebi et  al., 2013). NSAIDS, 
which are commonly given to patients for pain relief, block 
PG production. Acetaminophen, unlike NSAIDS, is inac-
tive as an anti-inflammatory agent in peripheral tissues and 
does not prevent PG synthesis and tooth movement. The 
aims of this study were to assess the efficacy of ibuprofen 
and acetaminophen administered before or after orthodontic 
activation with regard to pain control and PGE2 levels and 
to find possible associations between PGE2 released in GCF 
and the intensity of pain.
Pain is a subjective sensation and of multifactorial ori-
gin. Several methods were proposed for pain assessment 
in the literature and almost all of them rely on subjective 
recordings. Verbal rating scales, behavioural rating scales, 
and numeric scales are the commonly used methods (Polat, 
2007). Like most of the studies in orthodontic literature, a 
VAS was used for pain assessment in this study. Although 
it does not provide an objective recording, VAS was found 
superior to other pain scales in terms of reproducibility and 
ease of measurement (Dubner, 1978; Seymour et al., 1985).
When previous studies on analgesic efficiancy of ibu-
profen, acetaminophen and placebo on orthodontic pain 
were reviewed, conflicting results were seen. Bernhardt 
et al. (2001) found that patients who took both preopera-
tively and/or postoperatively administrated ibuprofen felt 
less pain than other analgesics. Bradley et al. (2007) have 
found less pain in their ibuprofen group compared to aceta-
minophen. One of the latest studies on orthodontic pain has 
also shown that acetaminophen and placebo have similar 
analgesic activity, whereas ibuprofen had significant effects 
on lowering orthodontically induced pain (Patel et  al., 
2011). However Bird et  al. (2007) have shown that simi-
lar results were seen between acetaminophen and ibuprofen 
after the placement of separators on molar teeth. Similarly, 
Salmassian et al. (2009) have found no differences between 
the two drugs. In a systematic review that was published 
recently, it was shown that no statistical differences were 
detected between placebo, ibuprofen or acetaminophen 
(Xiaoting et al., 2010). The results of the present study also 
could not show differences in pain levels of patients taking 
Table 3 Distribution of PGE2 concentrations in the groups in time.
Follow-up Ibuprofen Acetaminophen Placebo P
After initial archwire −1.16 (−18.52–50.29) 0 (−23.75–33.14) −5.85 (−37.27–27.51) 0.879
Day 1 0 (−8.20–19.82) 0 (−30.12–142.55) −1.18 (−34.32–53.41) 0.486
Day 2 −6.23 (−41.03–20.16) 0 (−28.01 – 22.43) −1.8 (−47.61–8.96) 0.863
Day 3 −1.6 (−26.29–14.89) 0 (−32.68 – 40.43) −6.04 (−42.75–11.42) 0.522
Day 7 −2.79 (−32.06–11.14) −3.06 (−27.11–7.79) −6.98 (−28.37–28.80) 0.792
A confidence value of P < 0.0011 was determined after Bonferroni correction.
Table 4 Correlation coefficients between PGE2 levels and pain.
Groups After IA Day 1 Day 2 Day 3 Day 7
Ibuprofen Correlation coefficient (P) −0.398 (0.142) −0.313 (0.256) 0.158 (0.575) −0.040 (0.888) −0.056 (0.842)
Acetaminophen Correlation coefficient (P)  0.04 (0.887)  0.47 (0.077) 0.538 (0.039)  0.285 (0.303)  0.147 (0.601)
Placebo Correlation coefficient (P) −0.128 (0.649)  0.114 (0.685) 0.043 (0.879) −0.036 (0.899) −0.294 (0.287)
Ibuprofen + 
Acetaminophen
Correlation coefficient (P) −0.198 (0.295) −0.142 (0.454) 0.136 (0.473)  0.14 (0.462) −0.112 (0.555)
A confidence value of P < 0.0011 was determined after Bonferroni correction.
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placebo, ibuprofen or acetaminophen. Some possible rea-
sons were questioned for this result. First of all, only two 
doses were administrated for this study, which may be inad-
equate to detect statistically significant differences. Doses of 
400 mg ibuprofen and 600 mg acetaminophen were shown 
to be superior to placebo for dental pain but some investiga-
tors advised orthodontic patients to use regular doses for the 
first week of appliance placement (Salmassian et al., 2009; 
Bradley et al., 2007; Polat et al., 2005). One other possi-
ble reason can be the strong psychological effect of placebo 
drugs, which should not be underestimated. The present 
study model was a double-blind, placebo-controlled study 
and therefore the effect of the placebo could be obtained at 
a higher level. It was shown by Bouncher (1999) in medi-
cal and dental studies that the placebo effects could be as 
high as 30–40 per cent. In a previous study by Bartlett et al. 
(2005), it was shown that even a structured telephone call 
asking about how the patients felt in the first week after 
bonding, significantly lowered pain levels.
Different inflammatory mediators like PGE2, IL-1β, 
IL-6 and substance P is released during orthodontic tooth 
movement. In a canine retraction model, the levels of PGE2 
and IL-1β showed rapid increases in the first 24 hours of 
appliance placement and returned to baseline levels after 
the first week compared with the contralateral control 
group (Grieve et al., 1994). In a different study that used 
the same model, the efficacy of aspirin and rofecoxib was 
investigated on PGE2 concentrations in GCF (Sari et al., 
2004). It was shown that both of the drugs lowered PGE2 
levels on the first and second day of appliance placement, 
whereas PGE2 levels of placebo group showed a significant 
rise only on the first day and did not change for the rest of 
the week. Contrary to these results, in premolar extraction 
patients, IL-1β and TNF-α did not show significant 
differences during levelling in Day 7 and 21, but showed 
a rapid rise on sixth month when 150 g force was applied 
for canine distalization (Başaran et al., 2006). The results 
of this study did not find significant differences in PGE2 
levels with acetaminophen, ibuprofen, and placebo. The 
study model of this group was not an extraction model. 
Only nonextraction patients were included and evaluations 
were made only on the first week of levelling. According 
to Başaran et al., PGE2 levels reached a significant level 
only during canine distalization and not during levelling. 
In a study where the effect of light (50 g) and heavy 
(150 g) forces of the release of IL-1β, it was shown that 
the changes were not significant on the first hour, first 
day and first week in group where light force was applied 
(Luppanapornlarp et al., 2010). Therefore, the similarities 
between the groups of the current study could be attributed 
to the low levels of force during levelling. However, the 
results of these studies should be interpreted with caution. 
It was assumed that the repeatability of GCF collection 
and quantification procedures show large variations, 
which may indicate large intersubject and intrasubject 
errors (Perinetti et al., 2013). In a study by Perinetti et al. 
(2013), no systematic error was found but the method 
error (i.e. intrasubject variability) ranged from 40 to 58 
per cent for overall gingival fluid. Ongoing controversy 
also exist in using PGE2 level or concentrations and so far 
no consensus have been reached.
Only two studies are present in the orthodontic literature 
that try to find a relation between the perception of pain 
and the level of inflammatory mediators (Sari et al., 2004; 
Giannopoulou et  al., 2006). Giannopoulou et  al. (2006), 
tried to find a correlation between pain levels and IL-1β, 
PGE2 and substance P levels at first hour, first and seventh 
days after elastic separator placement. Their results revealed 
no significant correlation between PGE2 levels and pain but 
significant correlation between IL-1β and pain levels was 
detected on the first day. In another study, IL-1β, PGE2 
and substance P levels in pressure and tension regions 
were investigated and significant differences were detected 
in pressure region (Sari et al., 2004). In the present study, 
no specific pressure or tension regions are present, which 
would explain the differences with our results and the cur-
rent literature.
Orthodontic tooth movement is not controlled by only 
one chemical mediator. It is a multifactorial process and 
1–2  day analgesic use during the most painful first week 
of fixed appliance placement seems not to interfere with 
future tooth movement (Giannopoulou et al., 2006; Polat, 
2007; Ngan et al., 1994). However, in patients with chronic 
 illnesses like juvenile rheumatoid arthritis, osteoarthritis or 
gout, where long-term analgesic consumption is needed, 
special attention should be given.
Conclusions
1. The perception of pain by patients taking ibuprofen and 
acetaminophen at pre- or post-appliance placement was 
not different from patients taking placebo.
2. No time-related differences in PGE2 level were found 
between the groups.
3. No significant correlation was found between the per-
ception of pain and PGE2 levels.
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